论文部分内容阅读
目的:探讨对糖尿病合并肾病患者利用血液透析方法进行治疗所取得的临床效果。方法:选择曾于我院进行治疗的54例糖尿病合并肾病患者,这些患者中,有27例患者为糖尿病终末期肾病患者,将其作为观察组,另外27例为非糖尿病终末期肾病患者,将其作为对照组,对这两组患者均进行血液透析治疗,完成治疗后对两组患者的临床治疗效果进行比较。结果:在完成治疗之后,比较两组患者的并发症发生率,观察组中患者高于对照组,比较两组患者1年以及3年死亡率,观察组中患者高于对照组,首次透析时,观察组中存活患者与死亡患者在肾功能方面比较,有显著差异存在。结论:利用血液透析方法对糖尿病合并肾病患者进行治疗,可取的较好临床效果,能够使患者生还率得到有效提高,但是在进行透析时,要掌握好透析最佳时机,并且要对心血管疾病进行较好预防以及控制,从而使治疗效果得以提高,提高患者的生存质量。
Objective: To investigate the clinical effect of hemodialysis on patients with diabetic nephropathy. METHODS: Fifty-four patients with diabetic nephropathy who had been treated in our hospital were enrolled. Twenty-seven of these patients were diabetic end-stage renal disease and were included in the observation group. Another 27 patients were those with non-diabetic end-stage renal disease. As a control group, hemodialysis was performed on both groups of patients, and after treatment, the clinical effects of the two groups were compared. RESULTS: Complications were compared between the two groups after completion of the treatment, with patients in the observation group being higher than those in the control group. The 1-year and 3-year mortality rates were compared between the two groups. Patients in the observation group were higher than those in the control group. There was a significant difference in the renal function between survivors and death patients in the observation group. Conclusion: The hemodialysis method for patients with diabetic nephropathy, preferably good clinical results, can make the patient’s survival rate has been effectively improved, but dialysis, we must grasp the dialysis the best time, and to cardiovascular disease Better prevention and control, so that the treatment can be improved and improve the quality of life of patients.